Evidence map›Paper›PMID 35008314›Full record

ArticleCancers2021

Sociodemographic and Medical Determinants of Quality of Life in Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC CLG Studies.

Charlotte Sleurs, Jammbe Musoro, Ali Rowsell, Michal Kicinski, Stefan Suciu, Sofia Chantziara, Corneel Coens, Madeline Pe, Pierre Missotten, Els Vandecruys and 10 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Impact of Oncologic Treatment on Health-Related Quality of Life of Children and Adolescents.Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 3 countries.

Charlotte SleursDepartment of Pediatric Hemato-Oncology, University Hospital Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-4480-8330
Jammbe MusoroEuropean Organisation for Research and Treatment of Cancer (EORTC), 1200 Brussels, Belgium.
Ali RowsellSchool of Health Sciences, University of Southampton, Southampton SO17 1BJ, UK.
Michal KicinskiEuropean Organisation for Research and Treatment of Cancer (EORTC), 1200 Brussels, Belgium.
Stefan SuciuEuropean Organisation for Research and Treatment of Cancer (EORTC), 1200 Brussels, Belgium.
Sofia ChantziaraSchool of Health Sciences, University of Southampton, Southampton SO17 1BJ, UK.
Corneel CoensEuropean Organisation for Research and Treatment of Cancer (EORTC), 1200 Brussels, Belgium.
Madeline PeEuropean Organisation for Research and Treatment of Cancer (EORTC), 1200 Brussels, Belgium.
Pierre MissottenUnité de Psychologie de la Sénescence, Université de Liège, 4000 Liege, Belgium.
Els VandecruysDepartment of Pediatric Hematology-Oncology, Ghent University Hospital, 9000 Ghent, Belgium.
Anne UyttebroeckDepartment of Pediatric Hemato-Oncology, University Hospital Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-5644-424X
Marie-Françoise DresseDivision of Haematology-Oncology, Department of Paediatrics, University Hospital Liège, University of Liège, 4000 Liege, Belgium.ORCID 0000-0002-9777-1519
Claire PluchartDepartment of Pediatric Haematology and Oncology, CHU Reims, 51100 Reims, France.
Alina FersterDepartment of Hemato-Oncology, HUDERF (ULB), 1020 Brussels, Belgium.ORCID 0000-0002-9920-8359
Claire FreyconDepartment of Pediatric Hematology-Oncology, CHU Grenoble, 38700 Grenoble, France.
Jutte van der Werff Ten BoschDepartment of Pediatrics, UZ Brussel, 1090 Brussels, Belgium.
Pierre-Simon RohrlichPediatric Oncology, CHU Nice, 06200 Nice, France.
Yves BenoitDepartment of Pediatric Hematology-Oncology, Ghent University Hospital, 9000 Ghent, Belgium.
Anne-Sophie DarlingtonSchool of Health Sciences, University of Southampton, Southampton SO17 1BJ, UK.
Caroline PietteDivision of Haematology-Oncology, Department of Paediatrics, University Hospital Liège, University of Liège, 4000 Liege, Belgium.
European Organisation for Research and Treatment of Cancer · BEUniversity of Liège · BEUniversity of Southampton · GBGhent University Hospital · BEKU Leuven · BECentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Reims · FRQueen Fabiola Children's University Hospital · BEUniversitair Ziekenhuis Brussel · BE

Funding

Fonds Cancer QOL grant 013/2016Kom op tegen Kanker NAVzw Kinderkankerfonds NA
6 · The paper itself

Abstract

backgrounddue to increasing survival rates in childhood acute lymphoblastic leukemia (ALL), the number of survivors has been expanding. A significant proportion of these survivors can experience long-term emotional and psychosocial problems. However, the exact risk factors remain inconclusive. We investigated potential risk factors for decreased daily life quality and life challenges in long-term childhood ALL survivors enrolled between 1971 and 1998 in EORTC studies.

methodsself-report questionnaires were collected from 186 survivors (109 females; mean age at diagnosis 5.62 years, range 0.2-14.7; median time since diagnosis of 20.5 years (12.9-41.6)), including the Short-Form Health Survey (SF-12) and Impact of Cancer-Childhood Survivors (IOC-CS). Multivariable linear regression models were used to assess the impact of gender, age at diagnosis, relapse/second neoplasm, National Cancer Institute (NCI) risk group and cranial radiotherapy on 2 subscales of the SF-12 (physical and mental health) and five subscales of the IOC-CS (life challenges, body and health, personal growth, thinking and memory problems and socializing).

resultsmental component scores of SF-12 were not significantly associated with any risk factor. Physical component scores were lower in relapsed, irradiated and NCI high-risk patients. Regarding IOC-CS negative impact subscales, life challenges was more negatively impacted by cancer in female, younger (i.e., <6 years) and relapsed patients. Regarding the positive impact scales, personal growth was more positively impacted in relapsed patients, whereas body and health, and socializing, were less positively impacted in these patients, compared to non-relapsed patients. Socializing was more positively impacted in older patients (>6 years).

conclusionsthis study demonstrates that long-term outcomes can be both adverse and positive, depending on the patient's demographic and clinical characteristics. Younger, female, and relapsed patients might encounter more life challenges years after their disease, while physical challenges could occur more often in relapsed and high-risk patients. Finally, the positive effect on socializing in the older patients sheds new light on the importance of peer interactions for this subgroup. Specific individual challenges thus need specialized support for specific subgroups.

Indexed as

acute lymphoblastic leukemialong-term survivorshipquality of life

Identifiers

PMID35008314
PMCPMC8750449
OpenAlexW4200562792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.